Cancer

AstraZeneca AB

AstraZeneca is one of the world's leading pharmaceutical companies with a broad product portfolio of prescription drugs within many therapeutic areas: cancer, cardiovacular, gastrointestinal, infection, neuroscience and respiratory & inflammation. Wellknown products are Xylocain and Losec. The company has research and development departments in 7 countries. In Sweden, research specializes in respiratory diseases, gastrointestinal diseases and pain control. Astra has 19 production sites. The largest site is in Södertälje where 5000, of totally 14000 people involved in production, are working. Marketing in Sweden is done via Astra Zeneca AB.Headquarters are in London, and the R&D headquarters are situated in Södertälje. The company is listed on the Large Cap list at Stockholm Stock Exchange.

Members
Lundberg, Jan,
Andersson, Tommy B., Prof.
Julin, Per, Dr.
Storlien, Leonard Henry, Prof.
Olsson, Per G., Dr.
Afzelius, Lovisa, Associate Director

Manufacturing (Activities / Stage of development)
Neuroscience (Research / Therapy area)
Pharmaceutical (Academic research / Companies)
Phase I clinical trials (Activities / Stage of development)
Phase II clinical trials (Activities / Stage of development)
Phase III clinical trials (Activities / Stage of development)
Drug discov. and prod. dev. (Activities / Stage of development)

AstraZeneca AB
Västra Mälarehamnen 9
SE-151 85, Södertälje
Sweden
Phone: +46 8 553 260 00
Fax: +46 8 553 290 00
URL: Webpage

  


Banner 1

Banner 2

Banner 3